Full Text
Full text is available in PDF
Official Journal of Research Center for Gastroenterology and Liver Diseases
e-ISSN 1735-3408
p-ISSN 1735-143X
What is the performance of the Aspartate Aminotarnsferase to platelets Ratio Index in patients With Chronic Liver Disease?
Authors
1Department of Hepatology and Gastroenterology, Digi-DUne Research Center, Grenoble University Hospital, Medical officer of the pole, JpZarski@chu-grenoble.fr, France
*Corresponding Author: Department of Hepatology and Gastroenterology, Digi-DUne Research Center, Grenoble University Hospital, Medical officer of the pole, JpZarski@chu-grenoble.fr, France. Tel: +33-476765441. Fax: +33-476765179. Email: JpZarski@chu-grenoble.fr
Published online:Dec 31, 2011
Article type:Letter
Received:Mar 27, 2011
Accepted:Dec 24, 2011
How to Cite:Zarski J. What is the performance of the Aspartate Aminotarnsferase to platelets Ratio Index in patients With Chronic Liver Disease?. Hepat Mon. 2011;11(12):. doi: https://doi.org/10.5812/kowsar.1735143X.798
Abstract
This article does not have abstract.
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
31
Jul
2011
Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis
Roxana Sirli,
Ioan Sporea
Sirli R, Sporea I. Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis. Hepat Mon. 2011;11(7):. doi:
31
May
2011
Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?
Hadi Parsian
Parsian H. Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?. Hepat Mon. 2011;11(5):. doi:
31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
Omid Abedian,
Abolghasem Ajami,
Farshideh Abedian,
Araz Mirabi,
Ali-Reza Khalilian,
Hana Saffar
,et al.Abedian O, Ajami A, Abedian F, Mirabi A, Khalilian A, et al. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2012;12(5):. doi: https://doi.org/10.5812/hepatmon.6035
31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
Michael Adler
Adler M. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2011;11(7):. doi:
31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
Seyed Mohammadmehdi Hosseini Moghaddam
Hosseini Moghaddam SM. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2011;11(8):. doi: https://doi.org/10.5812/kowsar.1735143X.770
Cited by
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 0
Last Update: 2 weeks ago
- Scopus by Title (Ref): 0
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 6 days ago
- OpenAlex: 2
Last Update: 10 hours ago
- OpenCitations: 0
Last Update: 4 days ago
Comments
Number of Comments:0